13ᵗʰ International Symposium on Hodgkin Lymphoma
back to
back to
Program
Schedule
26.10.2024
27.10.2024
28.10.2024
Scientific Committee
Media
Photos
Videos
Downloads
Abstracts
Newsletters
Acknowledgements
Sponsors
Other Archives
ISHL13
ISHL12
Update on Hodgkin Lymphoma
ISHL11
ISHL10
ISHL9
ISHL8
ISHL7
Back to video list
IIntro: Treatment concepts in early-stage HL
Speaker
Marc André
Session
Limited Stages
Others Talks of this Session
Viewpoint: Systemic Therapy only in the future?
Viewpoint: CMT (is it there to stay?)
Factors driving treatment intensity in the whole cohort of patients with early-stage favorable (I-IIA), nonbulky Hodgkin Lymphoma enrolled in the RAFTING trial (NCT 04866654).
Nodular lymphocyte predominant Hodgkin lymphoma in the Nordic countries – characteristics, treatment and survival
Serum TARC Dynamics Correlate with Clinical Response and Metabolic Tumor Volume During Anti-PD1-Based First-Line HL Treatment in The GHSG Phase II NIVAHL Trial
This website uses cookies to ensure you get the best experience on our website. By using our site you agree to our use of cookies.
Learn more
Got it!